PWMG
HAE icon

Prestige Wealth Management Group’s Haemonetics HAE Stock Holding History

Prestige Wealth Management Group’s Portfolio HAE Stock Details HAE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$600 Hold
8
– – ﹤0.01% 1003
2026
Q1 		$451 Hold
8
– – ﹤0.01% 974
2025
Q4 		$642 Hold
8
– – ﹤0.01% 919
2025
Q3 		$390 Hold
8
– – ﹤0.01% 954
2025
Q2 		$597 Hold
8
– – ﹤0.01% 916
2025
Q1 		$509 Hold
8
– – ﹤0.01% 931
2024
Q4 		$625 Hold
8
– – ﹤0.01% 945
2024
Q3 		$644 Hold
8
– – ﹤0.01% 937
2024
Q2 		$662 Hold
8
– – ﹤0.01% 897
2024
Q1 		$683 Hold
8
– – ﹤0.01% 919
2023
Q4 		$685 Hold
8
– – ﹤0.01% 907
2023
Q3 		$717 Hold
8
– – ﹤0.01% 922
2023
Q2 		$682 Hold
8
– – ﹤0.01% 950
2023
Q1 		$662 Hold
8
– – ﹤0.01% 940
2022
Q4 		$629 Hold
8
– – ﹤0.01% 1032
2022
Q3 		$1K Hold
8
– – ﹤0.01% 852
2022
Q2 		$1K Hold
8
– – ﹤0.01% 864
2022
Q1 		$1K Buy
+8
New +$435 ﹤0.01% 878
2019
Q1 		– Sell
-5
Closed -$1K – 769
2018
Q4 		$1K Buy
+5
New +$525 ﹤0.01% 1027

Other funds holding HAE

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Neuberger Berman Group
Neuberger Berman Group New York $150B AUM 40.08% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return
AI
Ariel Investments Chicago, Illinois $10B AUM 42.59% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Citadel Advisors
Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Prestige Wealth Management Group's HAE Position: Q2 2026 in Review

Prestige Wealth Management Group held its Haemonetics (HAE) position steady in Q2 2026 at 8 shares worth $600. The position accounts for ﹤0.01% of the portfolio, ranked #1003.

Prestige Wealth Management Group first reported a position in HAE in Q4 2018 and has held it in 19 quarters since. The position peaked at $1K in Q3 2022. 329 funds tracked by Wall St. Rank hold HAE as of Q2 2026.

  • Prestige Wealth Management Group held 8 shares of Haemonetics worth $600 as of Q2 2026.
  • Prestige Wealth Management Group left its Haemonetics share count unchanged in Q2 2026.
  • Haemonetics made up ﹤0.01% of Prestige Wealth Management Group's portfolio in Q2 2026, its #1003 holding.
  • Prestige Wealth Management Group first reported a position in Haemonetics in Q4 2018 and has held it in 19 quarters since.
  • Prestige Wealth Management Group's Haemonetics position peaked at $1K in Q3 2022.
  • 329 funds tracked by Wall St. Rank held Haemonetics as of Q2 2026.

Based on Prestige Wealth Management Group's 13F filing for Q2 2026, filed 14 Aug 2026.